UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Frequency analyses of gastric pH in control and gastro‐oesophageal reflux disease subjects treated with a proton‐pump inhibitor

Alimentary pharmacology & therapeutics, 2004-12, Vol.20 (11‐12), p.1381-1386

2004

Volltextzugriff (PDF)

A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2008-10, Vol.135 (4), p.1130-1141

2008

Volltextzugriff (PDF)

Prucalopride induces high‐amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study

Neurogastroenterology and motility, 2016-09, Vol.28 (9), p.1341-1348

2016

Volltextzugriff (PDF)

Randomised clinical trial: the safety and efficacy of AST‐120 in non‐constipating irritable bowel syndrome – a double‐blind, placebo‐controlled study

Alimentary pharmacology & therapeutics, 2011-10, Vol.34 (8), p.868-877

2011

Volltextzugriff (PDF)

A Phase II dose ranging, double‐blind, placebo‐controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left‐sided ulcerative colitis

Alimentary pharmacology & therapeutics, 2006-05, Vol.23 (10), p.1415-1425

2006

Volltextzugriff (PDF)

Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left‐sided ulcerative colitis: a randomized, double‐blind, active‐controlled trial

Alimentary pharmacology & therapeutics, 2006-05, Vol.23 (10), p.1403-1413

2006

Volltextzugriff (PDF)

Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric‐coated aspirin 325 mg + immediate‐release omeprazole 40 mg) or enteric‐coated aspirin 325 mg + enteric‐coated omeprazole 40 mg – a randomised, phase 1, crossover study

Alimentary pharmacology & therapeutics, 2013-07, Vol.38 (1), p.62-71

2013

Volltextzugriff (PDF)

Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis

Alimentary pharmacology & therapeutics, 2006-05, Vol.23 (10), p.1427-1434

2006

Volltextzugriff (PDF)

Does the oral adsorbent AST-120 really improve symptoms for non-constipating irritable bowel syndrome? authors' reply

Alimentary pharmacology & therapeutics, 2012-01, Vol.35 (1), p.198-199

2012

Volltextzugriff (PDF)

Carbon-based compounds emerging as sparkling diamonds for IBS treatment? authors' reply

Alimentary pharmacology & therapeutics, 2012-01, Vol.35 (1), p.200-202

2012

Volltextzugriff (PDF)

Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment

Alimentary pharmacology & therapeutics, 2007-01, Vol.25 (1), p.103-109

2007

Volltextzugriff (PDF)

Review article: physiologic and clinical effects of proton pump inhibitors on non‐acidic and acidic gastro‐oesophageal reflux

Alimentary pharmacology & therapeutics, 2006-03, Vol.23 (s1), p.25-32

MINER, P. B.

2006

Volltextzugriff (PDF)

Intragastric acid control in non‐steroidal anti‐inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole

Alimentary pharmacology & therapeutics, 2006-04, Vol.23 (8), p.1189-1196

2006

Volltextzugriff (PDF)

Delayed rectal sensation with fecal incontinence: successful treatment using anorectal manometry

Gastroenterology (New York, N.Y. 1943), 1986-11, Vol.91 (5), p.1186-1191

1986

Volltextzugriff (PDF)

Omeprazole‐Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over‐the‐counter doses of proton pump inhibitors

Alimentary pharmacology & therapeutics, 2010-04, Vol.31 (8), p.846-851

2010

Volltextzugriff (PDF)

Failure of 5-aminosalicylic acid enemas to improve chronic radiation proctitis

Digestive diseases and sciences, 1989-05, Vol.34 (5), p.758-760

1989

Volltextzugriff (PDF)

Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis

Digestive diseases and sciences, 1992-04, Vol.37 (4), p.490-495

1992

Volltextzugriff (PDF)

The Role of the Mast Cell in Clinical Gastrointestinal Disease with Special Reference to Systemic Mastocytosis

Journal of investigative dermatology, 1991-03, Vol.96 (3), p.S40-S44

Miner, Philip B.

1991

Volltextzugriff (PDF)

Intravenous esomeprazole 40 mg vs. intravenous lansoprazole 30 mg for controlling intragastric acidity in healthy adults

Alimentary pharmacology & therapeutics, 2008-03, Vol.27 (6), p.483-490

2008

Volltextzugriff (PDF)

5-Aminosalicylic acid enemas: Effective agent in maintaining remission in left-sided ulcerative colitis

Gastroenterology (New York, N.Y. 1943), 1988-04, Vol.94 (4), p.1075-1079

1988

Volltextzugriff (PDF)

Effect of naproxen on gastric acid secretion and gastric pH

Alimentary pharmacology & therapeutics, 2006-06, Vol.23 (12), p.1719-1724

2006

Volltextzugriff (PDF)

Esophageal hypersensitivity may be a major cause of heartburn

The American journal of gastroenterology, 1999-03, Vol.94 (3), p.628-631

1999

Volltextzugriff (PDF)

Increased colonic mucosal mast cells associated with severe watery diarrhea and microscopic colitis

Digestive diseases and sciences, 1989-09, Vol.34 (9), p.1462-1465

1989

Volltextzugriff (PDF)

The effects of capsaicin on reflux, gastric emptying and dyspepsia

Alimentary pharmacology & therapeutics, 2000-01, Vol.14 (1), p.129-134

2000

Volltextzugriff (PDF)

A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn

Alimentary pharmacology & therapeutics, 2004-11, Vol.20 (9), p.975-982

2004

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(83)

Sprache

Englisch
(83)

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Humans
(64)
Life Sciences & Biomedicine
(63)
Gastroenterology & Hepatology
(49)
Biological And Medical Sciences
(48)
Male
(48)
Medical Sciences
(47)
Female
(46)
Adult
(38)
Middle Aged
(30)
Pharmacology. Drug Treatments
(28)
Digestive System
(26)
Gastroenterology. Liver. Pancreas. Abdomen
(25)
Pharmacology & Pharmacy
(23)
Aged
(19)
Adolescent
(15)
Other Diseases. Semiology
(15)
Cross-Over Studies
(14)
Hydrogen-Ion Concentration
(13)
Double-Blind Method
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Frequency analyses of gastric pH in control and gastro‐oesophageal reflux disease subjects treated with a proton‐pump inhibitor

A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease

Prucalopride induces high‐amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study

Randomised clinical trial: the safety and efficacy of AST‐120 in non‐constipating irritable bowel syndrome – a double‐blind, placebo‐controlled study

A Phase II dose ranging, double‐blind, placebo‐controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left‐sided ulcerative colitis

Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left‐sided ulcerative colitis: a randomized, double‐blind, active‐controlled trial

Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric‐coated aspirin 325 mg + immediate‐release omeprazole 40 mg) or enteric‐coated aspirin 325 mg + enteric‐coated omeprazole 40 mg – a randomised, phase 1, crossover study

Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis

Does the oral adsorbent AST-120 really improve symptoms for non-constipating irritable bowel syndrome? authors' reply

Carbon-based compounds emerging as sparkling diamonds for IBS treatment? authors' reply

Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment

Review article: physiologic and clinical effects of proton pump inhibitors on non‐acidic and acidic gastro‐oesophageal reflux

Intragastric acid control in non‐steroidal anti‐inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole

Delayed rectal sensation with fecal incontinence: successful treatment using anorectal manometry

Omeprazole‐Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over‐the‐counter doses of proton pump inhibitors

Failure of 5-aminosalicylic acid enemas to improve chronic radiation proctitis

Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis

The Role of the Mast Cell in Clinical Gastrointestinal Disease with Special Reference to Systemic Mastocytosis

Intravenous esomeprazole 40 mg vs. intravenous lansoprazole 30 mg for controlling intragastric acidity in healthy adults

5-Aminosalicylic acid enemas: Effective agent in maintaining remission in left-sided ulcerative colitis

Effect of naproxen on gastric acid secretion and gastric pH

Esophageal hypersensitivity may be a major cause of heartburn

Increased colonic mucosal mast cells associated with severe watery diarrhea and microscopic colitis

The effects of capsaicin on reflux, gastric emptying and dyspepsia

A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn

Suchergebnisse filtern